Convenience-Size Labeling Compliance Requires More Time, Money – Wyeth
This article was originally published in The Tan Sheet
Executive Summary
FDA underestimates the time firms will need and the costs they will face to comply with the agency's proposed rule for convenience-size OTC drug facts labeling, according to Wyeth Consumer Healthcare
You may also be interested in...
FDA Agenda Pushes Back Sunscreen Rule, Cough/Cold Dosing Proposal
FDA moved back its target dates for regulatory milestones including an OTC sunscreen monograph final rule and a proposed rule for pediatric dosing of cough/cold products
FDA Proposes Adverse Side-Effect Warnings Outside Convenience-Size OTCs
Exterior labels on convenience-size packages of OTC drugs should include warnings about potential adverse side effects for people with some pre-existing conditions, according to an FDA proposed rule
OTC Labeling Compliance Date Delayed For “Convenience-Size” Items
"Convenience-size" OTC drugs will not be required to meet "Drug Facts" reg compliance dates until FDA publishes either a final rule or further notice on the labeling of such products